We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+6.83%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$18.1B
AUM Growth
+$2.29B
Cap. Flow
+$1.49B
Cap. Flow %
8.21%
Top 10 Hldgs %
14.26%
Holding
1,826
New
616
Increased
338
Reduced
371
Closed
491

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$219M
2
TWX
Time Warner Inc
TWX
+$207M
3
DGX icon
Quest Diagnostics
DGX
+$161M
4
CVS icon
CVS Health
CVS
+$154M
5
PCG icon
PG&E
PCG
+$143M

Top Sells

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$162M
2
TXN icon
Texas Instruments
TXN
+$103M
3
AMZN icon
Amazon
AMZN
+$85.6M
4
DAL icon
Delta Air Lines
DAL
+$76M
5
NVDA icon
NVIDIA
NVDA
+$75.7M

Sector Composition

Rank Sector Weight
1 Healthcare 23.56%
2 Technology 14.21%
3 Consumer Discretionary 12.36%
4 Industrials 10.91%
5 Communication Services 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVEO
1326
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$54K ﹤0.01%
+1,921
New +$59.6K
EGLE
1327
DELISTED
Eagle Bulk Shipping Inc.
EGLE
$54K ﹤0.01%
+1,706
New +$53.8K
SDRL
1328
DELISTED
Seadrill Limited Common Stock
SDRL
$45K ﹤0.01%
728
-1,933
-73% -$154K
BTE icon
1329
Baytex Energy
BTE
$2.93B
$38K ﹤0.01%
+12,500
New +$36.8K
ICON
1330
DELISTED
Iconix Brand Group, Inc.
ICON
$37K ﹤0.01%
+2,889
New +$81.9K
ACGN
1331
DELISTED
Aceragen Inc
ACGN
$30K ﹤0.01%
+105
New +$30K
JONE
1332
DELISTED
Jones Energy, Inc.
JONE
$29K ﹤0.01%
+1,335
New +$31.2K
ATHX
1333
DELISTED
Athersys, Inc. Common Stock
ATHX
$26K ﹤0.01%
+568
New +$27.5K
ONSIW
1334
DELISTED
Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019
ONSIW
$4K ﹤0.01%
125,400
ONSIZ
1335
DELISTED
Oncobiologics, Inc. Series B Warrant
ONSIZ
$3K ﹤0.01%
125,100
AA icon
1336
Alcoa
AA
$12.5B
-31,042
Closed -$1.46M
ABG icon
1337
Asbury Automotive
ABG
$3.88B
-4,517
Closed -$276K
ACIC icon
1338
American Coastal Insurance
ACIC
$498M
-67,007
Closed -$1.07M
ACLS icon
1339
Axcelis
ACLS
$4.2B
-202,215
Closed -$5.46M
ACM icon
1340
Aecom
ACM
$9.63B
-21,021
Closed -$778K
ADI icon
1341
Analog Devices
ADI
$184B
-72,145
Closed -$6.21M
ADNT icon
1342
Adient
ADNT
$1.48B
-8,189
Closed -$688K
AEP icon
1343
American Electric Power
AEP
$68.2B
-35,465
Closed -$2.48M
AGI icon
1344
Alamos Gold
AGI
$13B
-741,995
Closed -$5.19M
AGNC icon
1345
AGNC Investment
AGNC
$12.6B
-85,991
Closed -$1.89M
AGX icon
1346
Argan
AGX
$8.28B
-59,558
Closed -$3.99M
AIR icon
1347
AAR Corp
AIR
$5.89B
-109,054
Closed -$4.14M
AIZ icon
1348
Assurant
AIZ
$14.7B
-105,086
Closed -$10.1M
AKAM icon
1349
Akamai
AKAM
$17.2B
-4,207
Closed -$206K
ALLY icon
1350
Ally Financial
ALLY
$13.4B
-298,712
Closed -$7.17M

Similar funds

Marshall Wace North America's Q4 2017 Portfolio in Review

As of Q4 2017, Marshall Wace North America held 1,826 positions worth $18.1B, up 14% from $15.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace North America deployed $1.49B of net new capital in Q4 2017, opening 616 new positions and adding to 338 existing holdings. Its largest new stake was Time Warner Inc: 2,188,772 shares worth $200M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Applied Materials, an estimated $162M trimmed.

  • Marshall Wace North America's largest Q4 2017 buy was Time Warner Inc: 2,188,772 shares worth $200M.
  • Marshall Wace North America added most to Boston Scientific in Q4 2017, an estimated $219M increase.
  • Marshall Wace North America's biggest Q4 2017 reduction was Applied Materials, cutting an estimated $162M.
  • Marshall Wace North America fully exited NVIDIA in Q4 2017, selling an estimated $75.7M.
  • Marshall Wace North America's ten largest holdings make up 14% of its $18.1B portfolio in Q4 2017.
  • Marshall Wace North America opened 616 new positions and closed 491 in Q4 2017.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $18.1B.

Based on Marshall Wace North America's 13F filing for Q4 2017, filed 14 Feb 2018.